Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Hydroxocobalamine on Outcome of Smoke Inhalation Injury Admitted to the ICU

NCT03558646 is registered in ClinicalTrials.gov with Saint-Louis Hospital, Paris, France as lead sponsor.

NCT NCT03558646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03558646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Hydroxocobalamine on Outcome of Smoke Inhalation Injury Admitted to the ICU
Lead sponsor
Saint-Louis Hospital, Paris, France
Phase
Observational
Overall status
Completed
Start date
June 1, 2017
Completion date
February 1, 2019
Enrollment
739 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoke inhalation patients